Abstract
The aim of this study was to investigate the feasibility of sentinel lymph node biopsy (SLNB) after neoadjuant chemotherapy (NAC) in breast cancer patients with confirmed axillary nodal metastases. We enrolled 51 patients with breast cancer who received NAC. All patients were proven to have axillary nodal metastases by histopathology biopsy prior to NAC. They all underwent SLNB before breast surgery, and complete axillary lymph node dissection immediately followed. The identification rate for SLNB was 87.5% (84/96); the false negative rate was 24.5% (12/49). The clinicopathological factors were not significantly correlated with the identification and false negative rate of the SLNB. Lymphatic mapping, blue dye or radionuclide methods tended to decrease the identification rate of SLNB (P = 0.073). Clinical nodal status before NAC has a trend to increase the false-negative rates of the SLNB (P = 0.059). For patients with N1 clinical axillary lymph nodal status, the identification rate was 93.9%, and the false negative rate was 5.9%, compared with N2-3 patients with 73.9% and 38.9%, respectively. SLNB is feasible for the patients whose axillary lymph nodal status before NAC is N1. However, for N2-3 patients, SLNB cannot be used as...Continue Reading
References
Oct 1, 1998·The New England Journal of Medicine·D KragP Beitsch
Feb 2, 1999·American Journal of Surgery·H M KuererS E Singletary
Jan 9, 2001·Cancer·K S NasonR E Moe
May 8, 2001·Nuclear Medicine Communications·A FernándezJ Martín Comín
Mar 14, 2003·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·José Roberto M PiatoJosé Aristodemo Pinotti
Oct 16, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Harry D BearUNKNOWN National Surgical Adjuvant Breast and Bowel Project Protocol B-27
Dec 9, 2003·The Breast : Official Journal of the European Society of Mastology·Keith N OgstonSteven D Heys
Mar 5, 2004·British Journal of Cancer·A A EzzatR Sorbris
Apr 20, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Eleftherios P MamounasNorman Wolmark
Sep 15, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gary H LymanUNKNOWN American Society of Clinical Oncology
Sep 17, 2005·American Journal of Surgery·Julie L JonesBarbara L Smith
Dec 6, 2005·The British Journal of Surgery·Y XingJ N Cormier
Dec 6, 2005·Cancer·Theodore KimGary H Lyman
Jan 31, 2006·American Journal of Surgery·Takayuki KinoshitaShoji Terui
Oct 26, 2006·Breast Cancer Research and Treatment·Seeyoun LeeEun Sook Lee
Mar 3, 2007·Cancer·Jeannie ShenKelly K Hunt
May 22, 2007·Annals of Surgical Oncology·Erika A NewmanLisa A Newman
Mar 4, 2008·Annals of Surgical Oncology·P GimberguesJ Dauplat
Jul 10, 2008·Surgery Today·Masato HinoKeiichi Homma
Dec 31, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jean-Marc ClasseSylvia Giard
Apr 7, 2009·Academic Radiology·Aine M KellyRuth C Carlos
Nov 3, 2009·ANZ Journal of Surgery·Tanfo T CheungAva Kwong
Jan 21, 2010·Cancer·Gordon F SchwartzJuan P Palazzo
Jul 19, 2012·World Journal of Surgery·Maiko TakahashiYuko Kitagawa
Citations
Mar 31, 2015·BioMed Research International·Hazem AssiAli Shamseddine
Oct 13, 2018·The British Journal of Surgery·S R TeeE W McDermott
Oct 13, 2018·Annals of Surgery·Janine M SimonsMarjolein L Smidt
May 1, 2021·Asian Journal of Surgery·Jianyi LiBo Chen
Jul 30, 2021·The Breast : Official Journal of the European Society of Mastology·Siyang CaoWei Wei